Specialty pharmaceutical and medical device company Delcath Systems Inc. (DCTH: Quote) said Thursday it plans to offer shares of its common stock and warrants to purchase shares of common stock in an underwritten public offering. Delcath said the offering is subject to market and other conditions.
Delcath said it expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock and warrants offered in the public offering to cover over-allotments, if any.
The company expects that the proceeds of the offering will mainly be used for general corporate purposes.
Cowen and Company, LLC and Wedbush PacGrow Life Sciences are acting as joint book-runners for the offering. Roth Capital Partners is acting as co-manager for the offering.
Click here to receive FREE breaking news email alerts for Delcath Systems Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: email@example.com